A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.
PHASE3CompletedINTERVENTIONAL
Enrollment
114
Participants
Timeline
Start Date
July 31, 2004
Conditions
Migraines
Interventions
DRUG
divalproex sodium
Trial Locations (1)
60064
Global Medical Information - Abbott, North Chicago